Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a s
about
Update and new approaches in the treatment of Castleman diseaseTwo Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal HemorrhagingThe first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease.Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.TAFRO syndrome: 2 cases and review of the literature.TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy.A case of TAFRO syndrome with a large mediastinal mass treated with debulking surgeryA case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy.Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature.Magnetic resonance imaging of bone marrow for TAFRO syndrome.International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.TAFRO syndrome: New subtype of idiopathic multicentric Castleman disease.Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids: The first case report in Latin America.Castleman's disease with TAFRO syndrome: a case report from SyriaAnasarca, Fever, Thrombocytopenia, Organomegaly, and Multiorgan Failure in a 24-Year-Old Pregnant Woman.Multicentric Castleman disease: Where are we now?Tocilizumab for uncontrollable systemic inflammatory response syndrome complicating adult-onset Still disease: Case report and review of literature.Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.Successful Treatment of TAFRO Syndrome with Tocilizumab, Prednisone, and Cyclophosphamide.Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion.Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome.Distinct features distinguishing IgG4-related disease from multicentric Castleman's disease.A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature.Durable remission with rituximab in a patient with an unusual variant of Castleman's disease with myelofibrosis-TAFRO syndrome.Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.The full spectrum of Castleman disease: 273 patients studied over 20 years.TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.Tentative diagnostic criteria and disease severity classification for Castleman disease: A report of the research group on Castleman disease in Japan.Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome.TAFRO syndrome: current perspectives.Sjögren's syndrome manifesting as clinicopathological features of TAFRO syndrome: A case report.High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.Idiopathic multicentric Castleman's disease: a clinicopathologic study in comparison with IgG4-related disease.
P2860
Q26740703-801F41ED-2C0A-45F6-BD86-51CD3A52C918Q32182008-04828C5C-F24E-46C5-8E27-AF9210CA0033Q33415700-BBFF0F04-AC23-4DDC-BF8B-D7AE37338F40Q33420286-5CEFAD18-EDE0-4C42-A6F7-92889A7F6EAEQ33423479-B594BBFF-0FD0-4831-B7BE-DD434FED89B2Q33430083-6B23D473-F24B-4EE6-AACF-ABDB785DB892Q33430748-E9BB244D-C77C-452A-983E-235D02EF15C7Q33431547-8A0BAC96-D7DC-4A81-A713-E1CCFCFBD0A7Q33432624-E2E96B97-728E-4152-A78F-9088986C0805Q33433216-FD2F7766-0527-4E34-A50E-13FC264BED94Q33433871-C4111928-9AEC-4364-8C73-447B7214DC75Q33434530-83CE7864-84EA-4920-B2AC-98C2FEF60395Q33435903-66416208-385B-41A3-8A38-FE4B9069B54DQ33436275-64D732D9-43A5-4C86-915B-60AE423B9421Q33436635-F2CC6C42-79A1-4296-B867-87CDD4B9C2B2Q33438403-8B34576F-0824-41DE-A669-D6726B6FD4F5Q33438812-623B9B6E-B01F-468F-85C8-50477D322970Q33439399-47773DB2-88CC-4564-87BE-85F80D537181Q33440516-6CF3D4A8-7B03-42D0-BF33-61B5097530ABQ33442420-F3BE41D7-2EEB-49B7-B3BA-E97B181EE576Q33443714-C34D9D32-2748-43FA-B537-4A0C628BDC90Q38863770-8C018206-910F-47ED-AC2C-FA77028F4AC2Q39445471-AC411D4D-024E-44C3-98A1-00EFB0D4131EQ40042816-A4B2D619-9879-4D65-B98D-9861A3B9149BQ40044420-02B75F1D-2905-4A8B-A857-E5FC825511E5Q40129035-A9F9EDFC-D80E-491F-9DEE-1F8FD5FC17CFQ41135124-1A021507-C334-4418-AA3B-8401D0AD92B8Q41678341-B6293274-A154-428A-AFE1-8E283E87FEFDQ41928746-553BEE77-0936-4C46-938F-344B8F34E1F9Q42364525-146F3366-93CD-4A5A-9B7C-1D79256773C7Q43242156-D0EFDF9B-43A8-4FF8-8F91-9BE69629229CQ47097223-727774C4-083C-4A6D-88E0-B1B82D9A41A9Q47578601-BE8111CE-EC75-4997-B9A8-39B97C113DCEQ47669677-112E4FB7-F990-4670-A879-B52136AD8B87Q47780672-98D3DD23-D559-4A38-B77E-EC5117FCA1A3Q48221132-97FBEB88-A0DA-47B7-AE92-9719D6998FC1Q49384282-E201BCCE-FF51-4284-AD28-C4F6A87DC18CQ49487524-5C21443A-089A-4EDC-88FB-C088200F8E30Q49723291-3E11C795-2DB3-479D-A045-CDA8F63F73E1Q50173216-617D4EFB-90D2-43E6-BB0C-CEFEFC0007BE
P2860
Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a s
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@en
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@nl
type
label
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@en
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@nl
prefLabel
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@en
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@nl
P2093
P356
P1476
Castleman-Kojima disease (TAFR ...... nction, and organomegaly : a s
@en
P2093
Hiroshi Kawabata
Kazue Takai
Masaru Kojima
Naoya Nakamura
Sadao Aoki
Shigeo Nakamura
Tomohiro Kinoshita
Yasufumi Masaki
P356
10.3960/JSLRT.53.57
P577
2013-01-01T00:00:00Z